Old Web
English
Sign In
Acemap
>
authorDetail
>
A. Belhadef
A. Belhadef
Medicine
Cardiotoxicity
Pharmacology
Doxorubicin
Programmed cell death
7
Papers
50
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
EPAC1 inhibition as a new therapeutic target in anthracyclines induced cardiotoxicity
2021
Archives of Cardiovascular Diseases Supplements
A. Belhadef
M. Ribeiro
Marianne Mazevet
Marion Laudette
Bertrand Crozatier
Frank Lezoualch
Jean-Pierre Benitah
Ana María Gómez
Eric Morel
Christophe Lemaire
Show All
Source
Cite
Save
Citations (0)
A modification of cAMP compartmentation is involved in the doxorubicin-induced cardiotoxicity
2021
Archives of Cardiovascular Diseases Supplements
D. Daydé
A. Belhadef
M. Barthe
Florence Lefebvre
Delphine Mika
Rodolphe Fischmeister
Eric Morel
Show All
Source
Cite
Save
Citations (0)
EPAC1 inhibition prevents adverse cardiotoxicity induced by anticancer treatment
2020
Archives of Cardiovascular Diseases Supplements
A. Belhadef
M. Ribeiro
Marianne Mazevet
Frank Lezoualch
Bertrand Crozatier
Jean-Pierre Benitah
Ana María Gómez
Christophe Lemaire
Eric Morel
Show All
Source
Cite
Save
Citations (0)
Anticancer therapy induced cardiotoxicity: Involvement of EPAC1 in cardioprotection and anticancer therapy
2019
Archives of Cardiovascular Diseases Supplements
A. Belhadef
E. Morel
Show All
Source
Cite
Save
Citations (0)
1